FIELD: food industry.
SUBSTANCE: desalinated composition of krill lipids containing 30–50 % w/w phospholipids; from 32 to 52 % w/w triglycerides; wherein said composition is characterized by the following properties: contains less than 0.2 % w/w inorganic salts; contains less than 2 ppm Cu++; contains less than 3 ppm of common arsenic and contains from 0.01 to 1 % w/w ethyl esters. Composition of krill phospholipids concentrate contains: from 50 to 85 % w/w phospholipids; from 5 to 35 % w/w triglycerides; and wherein said composition has the following properties: contains less than 0.2 % w/w inorganic salts; contains less than 2 ppm Cu++; contains less than 3 ppm of common arsenic and contains from 0.01 to 1 % w/w ethyl esters. Composition of krill lipids containing: 70 to 95 % w/w triglycerides; from 2 to 20 % w/w phospholipids; wherein said composition has the following properties: contains less than 0.2 % w/w inorganic salts; contains less than 2 ppm Cu++; contains less than 3 ppm of common arsenic and contains from 0.01 to 1 % w/w ethyl esters. Food additive contains desalinated composition of krill lipids, or krill phospholipids concentrate composition, or krill lipid composition. Therapeutic alimentation product containing a desalinated composition of krill lipids, or a composition of krill phospholipids concentrate, or a composition of krill lipids. Filler for peroral delivery containing desalinated composition of krill lipids, or krill phospholipids concentrate composition, or krill lipid composition. Functional food product containing a desalinated krill lipid composition, or a krill phospholipid concentrate composition, or a krill lipid composition. Nutritive additive containing a desalinated composition of krill lipids, or a composition of krill phospholipids concentrate, or a composition of krill lipids. Nutraceutical composition containing a desalinated composition of krill lipids, or a composition of krill phospholipids concentrate, or a krill lipid composition. Pharmaceutical composition containing a pharmaceutically acceptable carrier and a desalinated krill lipid composition, or a krill phospholipid concentrate composition, or a krill lipid composition.
EFFECT: invention allows to enhance quality of lipids, obtain products characterized by low viscosity, low odor, improved taste, improved stability, low content of lysophospholipids and low level of undesirable materials.
29 cl, 3 ex
